MedTrace Logo

FALCOn (Facteur AnthropoLogique Cancer Orl)

NCT03663985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2020-03-03

No results posted yet for this study

Summary

There are no studies on practitioner-related factors influencing decision-making in the field of carcinology of aerodigestive carcinomas. The objective of the study is to determine what are the anthropo-sociological factors in the surgeon, the oncologists and radiotherapists influencing decision making in ear, nose, and throat carcinology. Special attention will be paid to the practitioner's gender, age, geographical origin, place and institution of training, place of practice, volume of patients treated, access to or without reconstruction by microsurgery, his tendency or aversion to risk taking.

* Main objectives : To determine the individual professional and non-professional characteristics influencing physicians' decision-making in oncology of aerodigestive carcinomas between choices:

1. Surgery
2. Radio and / or chemotherapy
3. Support care
4. Neo-adjuvant chemotherapy and reassessment
* Secondary objectives : Identify if certain patient profiles may lead to heterogeneous treatment decisions i.e. Human Papillomavirus status, age, comorbidities, autonomy, etc.

Conditions

Interventions

OTHER

Groupe FALCOn

The objective of the study is to determine what are the anthropo-sociological factors in the surgeon, the oncologists and radiotherapists influencing decision making in ENT carcinology.

Sponsors & Collaborators

  • Onco-Occitanie (Toulouse)

    collaborator UNKNOWN

  • University Hospital, Caen

    collaborator OTHER

  • Centre Francois Baclesse

    collaborator OTHER

  • Institut Claudius Regaud

    lead OTHER

Principal Investigators

  • Agnès DUPRET-BORIES, PhD · Institut Claudius Regaud

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-15
Primary Completion
2018-12-31
Completion
2019-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03663985 on ClinicalTrials.gov